uniQure (QURE) Cash from Investing Activities (2016 - 2026)

uniQure's (QURE) quarterly Cash from Investing Activities came in at $98.6 million in Q1 2026, up 390.37% year-on-year from $20.1 million in Q1 2025, and up 122.33% quarter-over-quarter from -$441.4 million in Q4 2025.

uniQure (QURE) Cash from Investing Activities (2016 - 2026) Analysis & Trends

uniQure's Cash from Investing Activities history runs 11 years deep, the most recent figure standing at $98.6 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 390.37% year-over-year to $98.6 million in Q1 2026; TTM through Mar 2026 was -$243.2 million, a 304.19% decrease from a year earlier, with the FY2025 full-year figure at -$321.6 million, down 297.35% from the prior year.
  • Cash from Investing Activities grew to $98.6 million in Q1 2026 per QURE's latest filing, from -$441.4 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $98.6 million in Q1 2026 and bottomed at -$441.4 million in Q4 2025.
  • The 5-year median for Cash from Investing Activities is $20.1 million (2025), against an average of -$26.4 million.
  • Across the five-year window, Cash from Investing Activities plunged 6103.16% in 2023 and surged 2041.4% in 2024, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$168.2 million in 2022, then soared by 135.41% to $59.6 million in 2023, then slumped by 144.7% to -$26.6 million in 2024, then plunged by 1557.79% to -$441.4 million in 2025, then surged by 122.33% to $98.6 million in 2026.
  • Per Business Quant, the three latest QURE Cash from Investing Activities figures stand at $98.6 million (Q1 2026), -$441.4 million (Q4 2025), and $26.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 uniQure 2.41 Bn 2.41 Bn 3.34 Mn 98.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 98.56 Mn
Mar 31, 2026 98.56 Mn
Dec 31, 2025 -441.37 Mn
Dec 31, 2025 -441.37 Mn
Sep 30, 2025 26.58 Mn
Sep 30, 2025 26.58 Mn
Jun 30, 2025 73.07 Mn
Jun 30, 2025 73.07 Mn
Mar 31, 2025 20.10 Mn
Mar 31, 2025 20.10 Mn
Dec 31, 2024 -26.62 Mn
Dec 31, 2024 -26.62 Mn
Sep 30, 2024 47.67 Mn
Sep 30, 2024 47.67 Mn
Jun 30, 2024 77.94 Mn
Jun 30, 2024 77.94 Mn
Mar 31, 2024 63.99 Mn
Mar 31, 2024 63.99 Mn
Dec 31, 2023 59.56 Mn
Dec 31, 2023 59.56 Mn